Table 5.

Effect modification by age

SNPNoncarriersCarriersP*
Case/controlORCase/controlOR (95% CI)
SNP1
    Age ≤65132/1711.00169/1391.47 (1.09-2.00)0.22
    Age >65187/2031.00185/1671.20 (0.91-1.58)
SNP2
    Age ≤65127/1211.00184/1940.92 (0.68-1.24)0.48
    Age >65146/1491.00239/2311.04 (0.79-1.37)
SNP3
    Age ≤65146/1321.00163/1800.84 (0.63-1.14)0.27
    Age >65162/1631.00218/2101.04 (0.79-1.37)
SNP4
    Age ≤65193/1571.00118/1570.64 (0.47-0.86)0.01
    Age >65200/2031.00184/1771.02 (0.78-1.35)
SNP5
    Age ≤65146/1321.00151/1730.79 (0.59-1.07)0.18
    Age >65151/1581.00210/2061.00 (0.76-1.31)
SNP6
    Age ≤65227/2101.0073/1000.67 (0.47-0.94)0.53
    Age >65284/2621.0093/1090.79 (0.57-1.09)
SNP7
    Age ≤65190/1521.00120/1610.63 (0.46-0.85)0.01
    Age >65198/2001.00186/1761.05 (0.80-1.39)
SNP9
    Age ≤65250/2301.0051/790.59 (0.40-0.87)0.41
    Age >65299/2811.0070/890.72 (0.51-1.03)
SNP10
    Age ≤65153/1381.00144/1700.76 (0.56-1.02)0.17
    Age >65167/1671.00203/1961.03 (0.78-1.35)
SNP11
    Age ≤65258/2811.0037/241.61 (0.94-2.74)0.04
    Age >65330/3241.0032/400.78 (0.48-1.27)
SNP12
    Age ≤65236/2331.0073/800.91 (0.63-1.29)0.40
    Age ≤65279/2801.00104/941.12 (0.81-1.54)
SNP13
    Age ≤65222/2051.0073/1010.66 (0.47-0.94)0.03
    Age >65253/2541.00121/1091.13 (0.83-1.53)
SNP14
    Age ≤65227/2081.0073/1010.66 (0.46-0.93)0.06
    Age >65253/2581.00116/1141.00 (0.73-1.35)
SNP15
    Age ≤65278/2731.0021/340.60 (0.34-1.06)0.09
    Age >65318/3331.0037/331.12 (0.69-1.82)
SNP16
    Age ≤65232/2111.0056/860.59 (0.41-0.86)0.02
    Age >65255/2671.0095/901.05 (0.76-1.45)
  • * P is testing the significance of the interaction.